Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
health
abbvie
acorda therapeutics
ampyra
apokyn
apomorphine
author_name|malak saleh
biotechnology science
boston blog main
boston top stories
clinical trials
dalfampridine
disease & medical conditions
duopa
inbrija
language|en-us
life sciences
mylan
national blog main
national top stories
new york
new york blog main
new york top stories
parkinson's disease
paul matteis
provider_name|engadget
region|us
site|engadget
stiel
sunovion pharmaceuticals
tests & procedures
What
approved
3
×
patients
3
×
treatment
3
×
disease
drug
use
accessibility
acorda
agency
approval
authorizes
beta
blood
called
cannabis
casgevy
cbd
cell
cells
cope
currently
dea
decision
disorders
editing
epilepsy
epileptic
episodes
fast
fda
friday
gene
genetic
gets
healthcare
help
hereditary
huge
impact
landmark
Language
unset
Current search:
treatment
×
patients
×
approved
×
@engadget.com
5 months ago
UK authorizes first gene therapy for treating sickle cell disease
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@WIRED
6 years ago
Currently, CBD is a Schedule 1 drug like cannabis, and the DEA must reschedule it before the epilepsy medication can be sold. If approved, this would have ...
